Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study

S. Moiseev, A. Kronbichler, E. Makarov, N. Bulanov, M. Crnogorac, H. Direskeneli, K. Galesic, U. Gazel, D. Geetha, L. Guillevin, Z. Hrušková, MA. Little, A. Ahmed, SP. McAdoo, AJ. Mohammad, S. Moran, P. Novikov, CD. Pusey, C. Rahmattulla, V....

. 2021 ; 60 (10) : 4654-4661. [pub] 20211002

Language English Country Great Britain

Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22003514

Grant support
5-100 Russian Academic Excellence Project

OBJECTIVE: To investigate the occurrence of venous thromboembolic events (VTE) in a large cohort of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across the European Union, Turkey, Russia, UK and North America. METHODS: Patients with a definite diagnosis of AAV who were followed for at least 3 months and had sufficient documentation were included. Data on VTE, including either deep vein thrombosis or pulmonary embolism, were collected retrospectively from tertiary vasculitis centres. Univariate and multivariate regression models were used to estimate odds ratios (ORs) and 95% CIs. RESULTS: Over a median follow-up of 63 (interquartile range: 29, 101) months, VTE occurred in 278 (9.7%) of 2869 AAV patients with a similar frequency across different countries (from 6.3% to 13.7%), and AAV subtype [granulomatosis with polyangiitis: 9.8% (95% CI: 8.3, 11.6%); microscopic polyangiitis: 9.6% (95% CI: 7.9, 11.4%); and eosinophilic granulomatosis with polyangiitis: 9.8% (95% CI: 7.0, 13.3%)]. Most VTE (65.6%) were reported in the first-year post-diagnosis. Multiple factor logistic regression analysis adjusted for sex and age showed that skin (OR 1.71, 95% CI: 1.01, 2.92), pulmonary (OR 1.78, 95% CI: 1.04, 3.14) and kidney [eGFR 15-60 ml/min/1.73 m2, OR 2.86 (95% CI: 1.27, 6.47); eGFR <15 ml/min/1.73 m2, OR 6.71 (95% CI: 2.94, 15.33)] involvement were independent variables associated with a higher occurrence of VTE. CONCLUSION: Two-thirds of VTE occurred during the initial phase of active disease. We confirmed previous findings from smaller studies that a decrease in kidney function, skin involvement and pulmonary disease are independently associated with VTE.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003514
003      
CZ-PrNML
005      
20220127150141.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/rheumatology/keab071 $2 doi
035    __
$a (PubMed)33523099
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Moiseev, Sergey $u Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University $u Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia
245    10
$a Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study / $c S. Moiseev, A. Kronbichler, E. Makarov, N. Bulanov, M. Crnogorac, H. Direskeneli, K. Galesic, U. Gazel, D. Geetha, L. Guillevin, Z. Hrušková, MA. Little, A. Ahmed, SP. McAdoo, AJ. Mohammad, S. Moran, P. Novikov, CD. Pusey, C. Rahmattulla, V. Satrapová, J. Silva, B. Terrier, V. Tesař, K. Westman, DRW. Jayne
520    9_
$a OBJECTIVE: To investigate the occurrence of venous thromboembolic events (VTE) in a large cohort of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across the European Union, Turkey, Russia, UK and North America. METHODS: Patients with a definite diagnosis of AAV who were followed for at least 3 months and had sufficient documentation were included. Data on VTE, including either deep vein thrombosis or pulmonary embolism, were collected retrospectively from tertiary vasculitis centres. Univariate and multivariate regression models were used to estimate odds ratios (ORs) and 95% CIs. RESULTS: Over a median follow-up of 63 (interquartile range: 29, 101) months, VTE occurred in 278 (9.7%) of 2869 AAV patients with a similar frequency across different countries (from 6.3% to 13.7%), and AAV subtype [granulomatosis with polyangiitis: 9.8% (95% CI: 8.3, 11.6%); microscopic polyangiitis: 9.6% (95% CI: 7.9, 11.4%); and eosinophilic granulomatosis with polyangiitis: 9.8% (95% CI: 7.0, 13.3%)]. Most VTE (65.6%) were reported in the first-year post-diagnosis. Multiple factor logistic regression analysis adjusted for sex and age showed that skin (OR 1.71, 95% CI: 1.01, 2.92), pulmonary (OR 1.78, 95% CI: 1.04, 3.14) and kidney [eGFR 15-60 ml/min/1.73 m2, OR 2.86 (95% CI: 1.27, 6.47); eGFR <15 ml/min/1.73 m2, OR 6.71 (95% CI: 2.94, 15.33)] involvement were independent variables associated with a higher occurrence of VTE. CONCLUSION: Two-thirds of VTE occurred during the initial phase of active disease. We confirmed previous findings from smaller studies that a decrease in kidney function, skin involvement and pulmonary disease are independently associated with VTE.
650    _2
$a senioři $7 D000368
650    _2
$a ANCA-asociované vaskulitidy $x komplikace $x imunologie $7 D056648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a rizikové faktory kardiovaskulárních chorob $7 D000082742
650    _2
$a lidé $7 D006801
650    _2
$a ledviny $x imunologie $7 D007668
650    _2
$a nemoci ledvin $x epidemiologie $x imunologie $7 D007674
650    _2
$a plíce $x imunologie $7 D008168
650    _2
$a plicní nemoci $x epidemiologie $x imunologie $7 D008171
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a odds ratio $7 D016017
650    _2
$a regresní analýza $7 D012044
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a kůže $x imunologie $7 D012867
650    _2
$a kožní nemoci $x epidemiologie $x imunologie $7 D012871
650    _2
$a žilní tromboembolie $x epidemiologie $x imunologie $7 D054556
651    _2
$a Evropa $x epidemiologie $7 D005060
651    _2
$a Severní Amerika $x epidemiologie $7 D009656
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kronbichler, Andreas $u Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria
700    1_
$a Makarov, Egor $u Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia
700    1_
$a Bulanov, Nikolay $u Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University
700    1_
$a Crnogorac, Matija $u Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb, Croatia
700    1_
$a Direskeneli, Haner $u Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
700    1_
$a Galesic, Kresimir $u Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb, Croatia
700    1_
$a Gazel, Ummugulsum $u Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
700    1_
$a Geetha, Duvuru $u Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
700    1_
$a Guillevin, Loic $u Department of Internal Medicine, National Referral Center for Rare Systemic and Autoimmune Diseases, Hôpital Cochin, Paris, France
700    1_
$a Hrušková, Zdenka $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Prague, Czech Republic
700    1_
$a Little, Mark A $u Trinity Health Kidney Centre, Trinity Translational Medicine Institute $u Irish Centre for Vascular Biology, Tallaght University Hospital
700    1_
$a Ahmed, Adeel $u Beaumont Hospital, Dublin, Ireland
700    1_
$a McAdoo, Stephen P $u Department of Medicine, Centre for Inflammatory Disease, Imperial College London, London, UK
700    1_
$a Mohammad, Aladdin J $u Department of Rheumatology, Skåne University Hospital, Lund, Sweden $u Vasculitis and Lupus Clinic, Addenbrooke's Hospital Cambridge University Hospitals, Cambridge, UK
700    1_
$a Moran, Sarah $u Trinity Health Kidney Centre, Trinity Translational Medicine Institute
700    1_
$a Novikov, Pavel $u Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University
700    1_
$a Pusey, Charles D $u Department of Medicine, Centre for Inflammatory Disease, Imperial College London, London, UK
700    1_
$a Rahmattulla, Chinar $u Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
700    1_
$a Satrapová, Veronika $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Prague, Czech Republic
700    1_
$a Silva, Joana $u Department of Medicine, Centre for Inflammatory Disease, Imperial College London, London, UK
700    1_
$a Terrier, Benjamin $u Department of Internal Medicine, National Referral Center for Rare Systemic and Autoimmune Diseases, Hôpital Cochin, Paris, France
700    1_
$a Tesař, Vladimír $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Prague, Czech Republic
700    1_
$a Westman, Kerstin $u Department of Clinical Sciences Lund, Nephrology, Lund University, Lund, Sweden
700    1_
$a Jayne, David R W $u Department of Medicine, University of Cambridge, Cambridge, UK
773    0_
$w MED00011379 $t Rheumatology (Oxford, England) $x 1462-0332 $g Roč. 60, č. 10 (2021), s. 4654-4661
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33523099 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150137 $b ABA008
999    __
$a ok $b bmc $g 1751076 $s 1154663
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 60 $c 10 $d 4654-4661 $e 20211002 $i 1462-0332 $m Rheumatology $n Rheumatology (Oxford) $x MED00011379
GRA    __
$a 5-100 $p Russian Academic Excellence Project
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options